Start the conversation
We're coming up on the six-month anniversary of a chat we had about how a tiny number can yield big profits.
Back on Oct. 27, I noted that the roughly $3 trillion global information technology sector grew just 3.3% in last year's third quarter.
But I went on to say that if you find the right tech leader, then that aggressive company could grow earnings - and your stock profits - by a big multiple over that number.
I recommended to you a specific aggressive IT services company. In fact, I said that this profit powerhouse could double in price in as little as two years.
And already, it looks like my thesis was almost right on the nose.
This company has actually exceeded my forecast. Since that last report, the stock is already up 43%, beating the S&P 500's 5% return by eight-fold during the period.
So, I'm doubling down on that profit prediction.
To show you why, let's go through the five reasons this tech stock will double from here in less than a year...
Check Out That Client List
This company's incredible growth and huge investment returns all stem from the same basic idea we've been discussing for the last several years.
Simply stated, these days, every company is a tech company.
Companies just can't be competitive without tech platforms that provide big productivity gains.
With that in mind, let's look closer at ServiceNow Inc. (Nasdaq: NOW)...
The company formed in San Diego in 2004 when a group of techies and surfers banded together with a simple mission. They wanted to make the complex and all-consuming tasks of running an IT department easy to manage from the cloud.
A “Blueprint to Financial Freedom”: America’s #1 Trader used this secret to become a millionaire. Now he’s sharing it live on camera – and you could learn how to set up a series of $822… $1,190… $2,830 payouts every single week.
Thanks to its intense focus on providing the best IT-as-a-service (ITaaS), ServiceNow has racked up an impressive list of clients and partners.
More than 800 members of the Forbes Global 2000 use ServiceNow products. Its list of partners runs so many pages long, I got tired of hitting the "show more" button on the firm's website.
This tells me that ServiceNow has "winner" written all over it.
I'm really excited about this stock, so let's run it through the five filters of Your Tech Wealth Blueprint for finding quality tech stocks.
About the Author
Michael A. Robinson is a 36-year Silicon Valley veteran and one of the top tech and biotech financial analysts working today. That's because, as a consultant, senior adviser, and board member for Silicon Valley venture capital firms, Michael enjoys privileged access to pioneering CEOs, scientists, and high-profile players. And he brings this entire world of Silicon Valley "insiders" right to you...
- He was one of five people involved in early meetings for the $160 billion "cloud" computing phenomenon.
- He was there as Lee Iacocca and Roger Smith, the CEOs of Chrysler and GM, led the robotics revolution that saved the U.S. automotive industry.
- As cyber-security was becoming a focus of national security, Michael was with Dave DeWalt, the CEO of McAfee, right before Intel acquired his company for $7.8 billion.
This all means the entire world is constantly seeking Michael's insight.
In addition to being a regular guest and panelist on CNBC and Fox Business, he is also a Pulitzer Prize-nominated writer and reporter. His first book Overdrawn: The Bailout of American Savings warned people about the coming financial collapse - years before the word "bailout" became a household word.
Silicon Valley defense publications vie for his analysis. He's worked for Defense Media Network and Signal Magazine, as well as The New York Times, American Enterprise, and The Wall Street Journal.
And even with decades of experience, Michael believes there has never been a moment in time quite like this.
Right now, medical breakthroughs that once took years to develop are moving at a record speed. And that means we are going to see highly lucrative biotech investment opportunities come in fast and furious.
To help you navigate the historic opportunity in biotech, Michael launched the Bio-Tech Profit Alliance.
His other publications include: Strategic Tech Investor, The Nova-X Report, Bio-Technology Profit Alliance and Nexus-9 Network.